This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1992 Feb;26(2):265.

doi: 10.1177/106002809202600229.

Comment: Myasthenia gravis and ciprofloxacin

D S Maddix, A Stefani

PMID: 1554947
DOI: 10.1177/106002809202600229

Case Reports

Comment: Myasthenia gravis and ciprofloxacin

D S Maddix et al. Ann Pharmacother. 1992 Feb.

. 1992 Feb;26(2):265.

doi: 10.1177/106002809202600229.

Authors

D S Maddix, A Stefani

PMID: 1554947
DOI: 10.1177/106002809202600229

No abstract available

PubMed Disclaimer

Comment on

Therapeutic strategies for myasthenia gravis.
Keys PA, Blume RP. Keys PA, et al. DICP. 1991 Oct;25(10):1101-8. doi: 10.1177/106002809102501016. DICP. 1991. PMID: 1803801 Review.

Similar articles

Ciprofloxacin and myasthenia gravis.
Mumford CJ, Ginsberg L. Mumford CJ, et al. BMJ. 1990 Oct 6;301(6755):818. doi: 10.1136/bmj.301.6755.818-a. BMJ. 1990. PMID: 2224281 Free PMC article. No abstract available.
Possible exacerbation of myasthenia gravis by ciprofloxacin.
Moore B, Safani M, Keesey J. Moore B, et al. Lancet. 1988 Apr 16;1(8590):882. doi: 10.1016/s0140-6736(88)91627-3. Lancet. 1988. PMID: 2895386 No abstract available.
Myasthenia gravis and ciprofloxacin.
Roquer J, Cano A, Seoane JL, Pou Serradell A. Roquer J, et al. Acta Neurol Scand. 1996 Dec;94(6):419-20. doi: 10.1111/j.1600-0404.1996.tb00055.x. Acta Neurol Scand. 1996. PMID: 9017031 No abstract available.
[Tumor-associated myasthenia gravis and myasthenia syndrome].
Szobor A, Kas J, Klein M, Rigler A, Rakonczai G, Vincze L. Szobor A, et al. Orv Hetil. 1994 Jan 9;135(2):59-65. Orv Hetil. 1994. PMID: 8295771 Review. Hungarian.
Ocular myasthenia gravis.
March GA Jr, Johnson LN. March GA Jr, et al. J Natl Med Assoc. 1993 Sep;85(9):681-4. J Natl Med Assoc. 1993. PMID: 8120928 Free PMC article. Review.

See all similar articles

Cited by

Probable exacerbation of myasthenia gravis by ofloxacin.
Azevedo E, Ribeiro JA, Polónia J, Pontes C. Azevedo E, et al. J Neurol. 1993 Sep;240(8):508. doi: 10.1007/BF00874123. J Neurol. 1993. PMID: 8263560 No abstract available.
Overview of Side-Effects of Antibacterial Fluoroquinolones: New Drugs versus Old Drugs, a Step Forward in the Safety Profile?
Rusu A, Munteanu AC, Arbănași EM, Uivarosi V. Rusu A, et al. Pharmaceutics. 2023 Mar 1;15(3):804. doi: 10.3390/pharmaceutics15030804. Pharmaceutics. 2023. PMID: 36986665 Free PMC article. Review.
Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review.
Jones SC, Sorbello A, Boucher RM. Jones SC, et al. Drug Saf. 2011 Oct 1;34(10):839-47. doi: 10.2165/11593110-000000000-00000. Drug Saf. 2011. PMID: 21879778 Review.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
Medical
- MedlinePlus Health Information